These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4833652)

  • 41. [Interaction of benetazon with modified starches. I. Changes in the separation coefficient of benetazon in the hexane:water system by interaction with modified starches].
    Mitterhauszerová L; Králová K; Krasnec L
    Cesk Farm; 1979 Jul; 28(6):239-42. PubMed ID: 575073
    [No Abstract]   [Full Text] [Related]  

  • 42. [1st clinical test in rheumatology using a new derivative of phenylbutazone (trimethylgallic ester of phenylbutazone)].
    Pelegrín Navarro A
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):225-8. PubMed ID: 5307374
    [No Abstract]   [Full Text] [Related]  

  • 43. [Trimethylgallic ester of phenylbutazone, new derivative of phenylbutazone].
    Marqués J; Muriach V; Barceló P
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):229-32. PubMed ID: 5307375
    [No Abstract]   [Full Text] [Related]  

  • 44. [Some derivatives of 1,2-diphenyl-4-butyl-3, 5-pirazolidine-dione. II].
    FRANCHI G
    Farmaco Sci; 1956; 11(10):819-22. PubMed ID: 13414852
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparative studies on the action of 4-butyl-1,2-diphenyl-3, 5-pyrazolidinedione on embryonal fibroblasts, blood and bone marrow cells in vitro].
    ALBRECHT M; ESCHENBACH J; KRETSCHMER V
    Arzneimittelforschung; 1960 Aug; 10():606-12. PubMed ID: 13682160
    [No Abstract]   [Full Text] [Related]  

  • 46. [Toxicity and kinetics of the elimination of 4-butyl-2-phenyl-3, 5-pyrazolidinedione compared with that of the 1,2-diphenyl derivative].
    SCARSELLI V
    Farmaco Sci; 1959; 14(5):347-51. PubMed ID: 13663921
    [No Abstract]   [Full Text] [Related]  

  • 47. [The obtaining of desemulsifier of butylpyridin bromide (chloride)].
    Rumiantsev VI; Ezhov VA
    Med Prom SSSR; 1965 Aug; 19(8):37-9. PubMed ID: 5869972
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of 1,2-diphenyl-3,5-diexe-4-n-butyl-pyrazolidine on the permaeability of blood-brain-barrier in animal experiments].
    Tzonos T
    Arzneimittelforschung; 1967 Apr; 17(4):509-11. PubMed ID: 5632452
    [No Abstract]   [Full Text] [Related]  

  • 49. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photochemical decomposition of dissolved hydroxylated polybrominated diphenyl ethers under various aqueous conditions.
    Bastos PM; Eriksson J; Bergman A
    Chemosphere; 2009 Oct; 77(6):791-7. PubMed ID: 19726071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The osmotic behavior of normal, of inflamed, and of 1,2-diphenyl-4-butyl-3,5-pyrazolidinedione-treated rat liver slices].
    BURCK HC
    Arzneimittelforschung; 1960 Sep; 10():752-5. PubMed ID: 13688929
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of internal diseases with 4-butyl-1, 2-diphenyl-3, 5-pyrazolidinedione and a combination of this drug with 4-dimethylamino-2, 3-dimethyl-1-phenyl-3-pyrazolin-5-one].
    BEHRE R
    Arzneimittelforschung; 1958 Aug; 8(8):520-5. PubMed ID: 13584244
    [No Abstract]   [Full Text] [Related]  

  • 53. [Optimization of the composition of tablets of phenylbutazone and aminophenazone by means of trial planning].
    Welikowa E; Jonowa R; Jontschew C
    Pharmazie; 1977; 32(8-9):502-4. PubMed ID: 594116
    [No Abstract]   [Full Text] [Related]  

  • 54. [Contribution to the pharmacodynamic study of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidinopiperazine].
    La Barre J; Derouaux G; Oleffe-Koopmansch S
    Arch Int Pharmacodyn Ther; 1966 Apr; 160(2):265-83. PubMed ID: 5954030
    [No Abstract]   [Full Text] [Related]  

  • 55. [Acid-base equilibrium in connective tissue and dependent changes under the influence of 1, 2-diphenyl-4-butyl-3,5-pyrazolidinedione. 2. Practical performance of the investigations].
    ECKSTEIN M; LINDNER J; von SCHWEINITZ H
    Arzneimittelforschung; 1960 Nov; 10():902-9. PubMed ID: 13725632
    [No Abstract]   [Full Text] [Related]  

  • 56. [Acid-base equilibrium in connective tissue and dependent changes under the influence of 1, 2-diphenyl-4-butyl-3, 5-pyrazolidine-dione. 1. Theoretical basis].
    von SCHWEINITZ H; LINDNER J; ECKSTEIN M
    Arzneimittelforschung; 1960 Nov; 10():899-901. PubMed ID: 13749227
    [No Abstract]   [Full Text] [Related]  

  • 57. [Spectrophotometric determination of ketophenylbutazone and related keto derivatives after a reaction with diazotized sulfanilic acid].
    Svátek E; Hrádková A
    Cesk Farm; 1966 Feb; 15(2):76-80. PubMed ID: 5933841
    [No Abstract]   [Full Text] [Related]  

  • 58. Quantitative structure-property relationships for direct photolysis of polybrominated diphenyl ethers.
    Chen J; Wang D; Wang S; Qiao X; Huang L
    Ecotoxicol Environ Saf; 2007 Mar; 66(3):348-52. PubMed ID: 16488010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.
    YU TF; PATON BC; CHENKIN T; BURNS JJ; BRODIE BB; GUTMAN AB
    J Clin Invest; 1956 Apr; 35(4):374-85. PubMed ID: 13306779
    [No Abstract]   [Full Text] [Related]  

  • 60. Renal papillary necrosis in horses after phenylbutazone and water deprivation.
    Gunson DE; Soma LR
    Vet Pathol; 1983 Sep; 20(5):603-10. PubMed ID: 6636467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.